https://www.selleckchem.com/pr....oducts/740-y-p-pdgfr
OBJECTIVE Lipid profile represents a driver of cardiovascular risk in type 2 diabetes. The effect of chronic insulin therapy on cholesterol levels is unclear. We aim to evaluate the effect of basal insulin on lipid profile compared to other classes of anti-hyperglycaemic agents in type 2 diabetic patients. DESIGN We performed a meta-analysis of randomized controlled trials reporting changes of lipid parameters in type 2 diabetic patients randomized to basal insulin or other classes of anti-hyperglycaemic agents. RESULTS The
Like
Comment
Share
